How much does egg freezing cost in 2026?
The cost of egg freezing usually arrives as a single figure on a clinic page, weeks before the first consultation. It's a five-figure number large enough to change a year's savings plan, and a careful reader can see it against her bank balance long before she knows what's actually in it.
In the United States in 2026, that figure generally lands at $12,000 to $20,000 all in, where "all in" means procedure plus medications plus monitoring plus first-year storage. Cofertility's 2026 cost roundup puts the band there, breaking it into roughly $8,000 to $15,000 for the procedure and $3,000 to $6,000 for medications. CNY Fertility's 2026 guide clusters a representative national figure near $16,000 once monitoring and storage are in. Geography moves the band more than the brochure suggests, and price isn't a reliable proxy for quality.
A clinic quote is honest paperwork for one phase of one decision. Read it as a contract for getting eggs into storage, not a forecast of the full path. Ask what the quote actually includes: medications, when storage starts, how year two gets billed, what moving eggs would cost if she ever switched clinics, and what she'll owe when she comes back to use them. A quote can be precise and still be too narrow to plan from. The full cost of egg freezing arrives across years and across several invoices the clinic page rarely shows together: probability decides whether one cycle is enough at her age; storage runs every year the eggs stay frozen; the future-use cycle waits for her return; and an embryo-stage information question stays unanswered until eggs become embryos.
Why one cycle is rarely the cost
Egg freezing is sold as a procedure. It works as a funnel. Retrieved eggs become mature oocytes after the lab counts them. Mature oocytes become thaw survivors when she comes back. Thaw survivors become fertilized embryos. Fertilized embryos become blastocysts that can be biopsied. Each step takes attrition.
ASRM's 2021 evidence-based outcomes guideline puts live-birth efficiency per warmed mature oocyte at roughly 7.4 percent under 30, 7 percent at 30 to 34, 6.5 percent at 35 to 37, and 5.2 percent at 38 and above. The same guideline reports approximately 14 mature oocytes for a 70 percent chance of one live birth at 30 to 34, 15 at 35 to 37, and roughly 26 at 38 to 40. ASRM's framing carries as much weight as the numbers: "There is insufficient evidence to predict live birth rates after planned oocyte cryopreservation." Han and Seifer's 2023 review in Journal of Clinical Medicine carries the cleanest patient-readable conditional table from Goldman et al. 2017: 10 frozen mature oocytes give a 69 percent chance of at least one live birth at 35 or younger, 45 percent at 38, 30 percent at 40, and 20 percent at 42.
ASRM's 2023 ethics opinion states what that math does to the bill: at age 38, "approximately 25-30 cryopreserved oocytes are required to have a reasonable chance of having one child," and planned oocyte cryopreservation "will often require multiple cycles to attain a reasonable chance of having a child in the future." Three different calculators can tell the same 34-year-old that one cycle gives her a 75 percent, an 85 percent, or a 93 percent chance of one live birth, and that spread isn't because one model is right. The population, inputs, and assumptions differ. The funnel is the durable answer; if she wants to model her own attrition step by step, our IVF Calculator walks the funnel rather than asserting a single number.
What storage actually costs over time
After year one, US storage typically runs $500 to $1,000 per year, and Cofertility's roundup notes that "many people store their eggs for a decade or more." A $750 fee held for ten years is $7,500 on top of the headline retrieval cost, a recurring line item that rarely shares a paragraph with the cycle quote.
It's the storage clock.
A 38-year-old in an egg-freezing thread asks whether splitting clinics is worth it once the math includes paying more than one annual storage bill. That question generalizes: anyone with eggs at multiple clinics, or anyone who relocates while her cohort stays where it was retrieved, is renewing a recurring decision, not closing one.
The future-use cycle is the second invoice the menu does not print. When the patient returns, she pays roughly $12,000 nationally for the frozen-egg IVF cycle (thaw, intracytoplasmic sperm injection, embryo culture) and roughly $6,000 for the frozen embryo transfer, per CNY's 2026 national-average column. ASRM's Reproductive Facts patient page names the same three-phase structure (consultation through retrieval; storage; future use) and adds the line every reader should hold: "Freezing eggs is not a guarantee of future pregnancy or having a child." A candidate who froze 27 eggs at 34 returned at 39 with 100 percent thaw survival, four of twelve fertilized, and zero blastocysts: one outcome, not a rate, but a useful reminder that the funnel applies on the way out, too.
Coverage is shaped by federal preemption, not by state count. Elective egg freezing is, in ASRM's 2023 ethics-opinion words, "expensive, is usually self-pay." Some employer plans pay; some do not. RESOLVE names the ERISA carve-out plainly: "Employers who self-insure are exempt from the requirements of the law." The live, plan-by-plan picture lives on the Alliance for Fertility Preservation's coverage map. Don't budget from a state headline. Budget from the actual plan document.
Eggs versus embryos: the bill the menu doesn't show
Egg freezing preserves cells. Embryo freezing preserves something the lab can read. Preimplantation genetic testing for chromosomes (PGT-A), for a specific known monogenic mutation (PGT-M), and preimplantation genetic testing for polygenic conditions (PGT-P) all run on a biopsied blastocyst. Frozen eggs aren't biopsied. They aren't tested. The information they could carry exists later, after thaw, fertilization, and culture have happened, and only on the embryos that get there. The embryo-stage cost arithmetic for those tests sits on a separate page; it doesn't fold into the egg-freezing quote.
The trade-off cuts both ways. ASRM's 2023 ethics opinion frames the egg-freezing side directly: planned oocyte cryopreservation "can allow individuals to control their preserved gametes without the risk that a partner may retract consent to future use, as can happen with frozen embryos." Frozen eggs preserve timing and partner flexibility. Frozen embryos make embryo-stage screening possible, and they force some consent decisions sooner. The choice isn't which format is better in general; it's which information access matters more for a particular family.
Herasight does not freeze eggs or run IVF cycles. If the choice for a particular family is whether to keep timing flexible by banking eggs or to bank embryos so screening can happen before transfer, our counselors can walk through what each format preserves and what it defers.